Viewing Study NCT01864902


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-03-13 @ 2:30 PM
Study NCT ID: NCT01864902
Status: UNKNOWN
Last Update Posted: 2016-01-28
First Post: 2013-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module